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Regulation of CD1 Function
and NK1.1 T Cell Selection
and Maturation by Cathepsin S
the sole CD1 gene product expressed in mice (Porcelli,
1995), presents lipid antigens to CD4 or double-nega-
tive NK 1.1 T cells, which express the invariant
V14J281 T cell receptor (TCR) paired with V8, V7, or
V2 (Lantz and Bendelac, 1994; Taniguchi et al., 1996).
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These cells can be characterized functionally by theirRichard Locksley,2 and Harold A. Chapman2,5
reactivity to the marine sponge-derived glycolipid,1 Department of Medicine
-GalCer. A second subset of CD1-restricted T cellsBrigham and Women’s Hospital and
was identified that expresses a more diverse set ofHarvard Medical School
TCRs, does not express the NK complex, and lacksBoston, Massachusetts 02115
reactivity to -GalCer (Behar et al., 1999; Cardell et al.,2 Department of Medicine
1995; Chiu et al., 1999). The semiinvariant TCR usageUniversity of California, San Francisco
by the -GalCer reactive T cells stands in sharp contrastSan Francisco, California 94943
to the variability of TCRs utilized by class I and class II3 Department of Pathology
antigen presentation pathways and suggests a differentHarvard Medical School
role in immunity of CD1-restricted T cells.4 Department of Cancer Immunology and AIDS
CD1-restricted T cells are also characterized by theirDana Farber Cancer Institute
rapid and robust release of cytokines upon stimulationBoston, Massachusetts 02115
(Hayakawa et al., 1992; Yoshimoto and Paul, 1994), in-
cluding IFN-, IL4, and IL10. This cytokine output influ-
ences the balance of the Th1/Th2 adaptive responsesSummary
during the initial stages of the immune response. The
rapid release of cytokines along with a more restrictedNK1.1 T cells develop and function through interac-
TCR usage may imply that CD1-restricted T cells playtions with cell surface CD1 complexes. In I-Ab mice
a prominent role in the innate immune response (Bende-lacking the invariant chain (Ii) processing enzyme, ca-
lac, 1995a; Shinkai and Locksley, 2000; Yoshimoto etthepsin S, NK1.1 T cell selection and function are im-
al., 1995). Experimentally, CD1-restricted T cells havepaired. In vitro, thymic dendritic cells (DCs) from cathep-
been implicated in preventing development of diabetessin S/ mice exhibit defective presentation of the CD1-
mellitus and protecting against parasitic infection (Scho-restricted antigen, -galactosylceramide (-GalCer).
field et al., 1999; Wilson et al., 1998).CD1 dysfunction is secondary to defective trafficking
An important characteristic of murine CD1d is its ex-of CD1, which colocalizes with Ii fragments and accu-
posure to endocytic compartments during intracellularmulates within endocytic compartments of cathepsin
trafficking (Brossay et al., 1998b; Chiu et al., 1999; Shin-S/ DCs. I-Ak, cathepsin S/ mice do not accumulate
kai and Locksley, 2000). CD1d molecules are synthe-class II-associated Ii fragments and accordingly do
sized within the endoplasmic reticulum and associatenot display CD1 abnormalities. Thus, function of CD1
with 2-microglobulin shortly after biosynthesis. Afteris critically linked to processing of Ii, revealing MHC
traversing the Golgi apparatus, CD1 complexes areclass II haplotype and cathepsin S activity as regula-
transported to the cell surface, whereupon they encoun-tors of NK T cells.
ter, bind, and display certain lipid and glycolipid anti-
gens. Surface-displayed CD1 molecules may be inter-Introduction
nalized to endosomes, and colocalize with MHC class
II molecules via a tyrosine-based targeting motif in the
CD1 molecules are nonpolymorphic proteins with struc- cytoplasmic tail of CD1(Jackman et al., 1998). This endo-
tural similarities to major histocompatibility complex somal trafficking is critical for the presentation of some,
(MHC) class I molecules (Brossay et al., 1998a; Porcelli but not all, CD1-displayed antigens. Cells expressing
and Modlin, 1999; Shinkai and Locksley, 2000). Like mutant CD1 molecules that lack the tyrosine-based in-
MHC class I molecules, CD1 heavy chains associate ternalization motif are unable to activate NK1.1
with 2-microglobulin within the endoplasmic reticulum V14J281 T cells but can stimulate non-NK CD1-
and present antigens to T cells. In contrast to MHC class restricted T cells (Chiu et al., 1999). Thus, “sampling” of
I, CD1 proteins are encoded by genes outside the MHC, the endocytic environment by CD1 molecules exposes
do not require the transporter associated with antigen CD1 to endosomal antigens as well as to the MHC class
processing (TAP) protein, and possess a hydrophobic II-related machinery. This, in turn, creates a potential for
antigen binding groove that binds lipid and glycolipid “crosstalk” between the class II and CD1 presentation
antigens (Beckman et al., 1994; Burdin and Kronenberg, pathways.
1999; Kawano et al., 1997; Porcelli et al., 1992). Whereas Two cysteine proteases, cathepsins S and L, play
“classical” class I molecules present peptide antigens prominent roles in invariant chain (Ii) degradation and
to CD8 T cells, CD1 presents lipid antigen to and stimu- MHC class II maturation in two different cell types. The
lates a subset of CD4 and CD4CD8 T cells. CD1d, activity of cathepsin S is tightly linked to Ii degradation
and intracellular trafficking of class II-Ii and class II-peptide
complexes in B cells and DCs (Driessen et al., 1999;5 Correspondence: halchap@itsa.ucsf.edu
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Nakagawa et al., 1999; Riese et al., 1996; Shi et al., from lack of positive selection (Chen et al., 1997; Mendir-
atta et al., 1997) (Figure 1B). Since the cathepsin S and1999). Antigen-presenting cells (APCs) from I-Ab mice
that lack cathepsin S activity fail to completely degrade CD1d genes are both located on mouse chromosome
3, one simple explanation for the deficiency in NK1.1Ii, with attendant accumulation of a class II-associated
10 kDa Ii fragment (lip10 Ii) within endosomes and dis- T cell selection observed in cathepsin S knockout mice
would be the absence of CD1 expression, either throughruption of normal class II intracellular trafficking (Driessen
et al., 1999). This, in turn, impedes class II-peptide com- inadvertent disruption of the gene with the cathepsin
S/neo construct or by another, less obvious, mecha-plex formation and class II-restricted antigen presenta-
tion of some, but not all, peptide antigens. Given these nism. However, the finding that cells from cathepsin
S/ mice express CD1 at levels equal to that of wild-dramatic alterations in class II biochemistry in cathepsin
S/ mice, its phenotype has been ascribed largely to type control mice on thymocytes, splenocytes, and flt3
ligand (flt3L)-derived DCs eliminates this explanationthese changes. However, this may be a naive assump-
tion, as the other effects of cathepsin S deficiency on (Figure 1D). This prompted us to investigate CD1d func-
tion as an alternative explanation for the NK1.1 T cellimmune function remain to be investigated. Cathepsin
L plays a role analogous to cathepsin S, but does so in defect.
cortical thymic epithelial cells (Nakagawa et al., 1998).
Cathepsin L/ mice have reduced CD4 T cells, attrib- CD1d-Restricted Antigen Presentation
uted to aberrant positive selection driven by cortical Is Defective in Cathepsin S/ Mice
thymic epithelial cells. Can aberrant antigen presentation by CD1 account for
The T cell selection defect found in cathepsin L-defi- defective NK1.1 T cell selection? To study potential
cient mice combined with cathepsin S’s similar role in conformational alterations of cell surface CD1d com-
bone marrow-derived APCs, and potentially thymic den- plexes between wild-type and cathepsin S/ APCs,
dritic cells, led us to hypothesize that the cathepsin S/ thy1.2-depleted splenocytes were utilized to stimulate
mice might also exhibit abnormal T cell selection. While a panel of CD1-restricted T cell hybridomas (Figure 2A).
preliminary analyses showed no overt defect in CD4 Five of these hybridomas express the invariant
or CD8 T cell populations, the data reported here show V14J281 TCR (3C3, DN32, 24.7, 24.8, 24.9) and three
a defect in thymic NK1.1T cell selection and maturation express a more variable TCR  chain (14S.6, 14S.7,
and dysfunctional CD1-restricted antigen presentation 14S.10) (Behar et al., 1999; Gumperz et al., 2000). Several
by thymic DCs. These abnormalities appear to be caus- of these hybridomas, notably 3C3, 24.9, 14S.7, and
ally related to accumulation of Ii fragments and MHC DN32, recognize CD1d complexes on wild-type APCs
class II-Ii complexes, which disrupt normal trafficking much more readily than on cathepsin S/ cells. Hybrid-
of CD1d molecules. oma 24.8 exhibits no difference in stimulation and IL2
generation between wild-type and cathepsin S-deficient
splenocytes. Interestingly, clone 14S.6 consistentlyResults
demonstrates moderately increased activation when in-
cubated with cathepsin S/ APCs. These data suggestCathepsin S/ Mice Exhibit Defective
NK1.1 T Cell Selection that there are conformational alterations of CD1d on
cathepsin S/ APC, potentially representing CD1dWe investigated T cell populations in the cathepsin
S-deficient mouse. Peripheral or thymic CD4 and CD8 complexes associated with different antigenic epitopes.
Thus, absence of cathepsin S activity alters CD1d func-T cell populations appear normal in cathepsin S/ mice.
However, further investigations reveal the surprising tion by affecting the cell surface antigenic display.
Do alterations in CD1d function also exist on thymicfinding that in I-Ab, cathepsin S/ mice NK1.1 T cells
are reduced in thymus and spleen, as demonstrated by class II cells from cathepsin S/ mice, thus providing
a possible link between cathepsin S activity and NK1.1decreased staining for the NK1.1 antigen (Figure 1A).
The magnitude of this reduction is slightly less than that T cell selection/maturation? Class II APCs comprise
about 1%–2% of our thymocyte cell preparations. Sinceseen in CD1/ animals (Figure 1B). Interestingly, Ii/,
but not class II/, mice exhibit a similar defect in NK1.1 direct stimulation of T cell hybridomas requires at least
7.5  106 cells/hybridoma, we needed to amplify theT cell selection, implicating Ii expression and/or pro-
cessing as an element that contributes to selection of signal in order to detect differences in CD1d function in
thymocyte class II APC. To do this, we utilized the CD1NK1.1 T cells (Figure 1A). Two other methods for de-
tecting invariant V14J281 T cells include double stain- “superantigen,” -GalCer, that simultaneously stimu-
lates all T cells expressing V14J281 TCR, and engen-ing for CD44high/V8 T cells (Figure 1B) and staining
with CD1--galactosylceramide tetramers (Figure 1C) ders a rapid and robust release of IFN- and IL4. As
shown in Figure 2B, thymocytes from the cathepsin S/(Benlagha et al., 2000; Matsuda et al., 2000). Both meth-
ods reveal decreases in this cell population similar to mice exhibit a marked defect in generation of cytokines
in response to -GalCer, with the generation of IFN-that by utilizing an antibody against the NK1.1 T cell
antigen, confirming our observations. There are no ob- affected more than IL4. Thymocyte suspensions defi-
cient in class II cells fail to elicit a normal cytokineservable differences in double-negative, single-positive,
or double-positive thymocytes between wild-type and response, indicating that class II cells are the primary
APCs mediating presentation of -GalCer and stimula-cathepsin S/ mice. Thus, the percentage decrease in
NK1.1 T cell selection in cathepsin S/ mice is also tion of NK1.1 T cells.
Is the blunted IFN- and IL4 response observed inreflected in absolute numbers.
Mice deficient in CD1d are devoid of NK1.1 T cells, these thymocyte preparations a consequence of low
Cathepsin S Regulates NK1.1 T Cell Selection
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Figure 1. Defective NK1.1 T Cell Selection in I-Ab, Cathepsin S/ Mice
(A) Splenocytes, thymocytes, and depleted thymocytes from I-Ab, wild-type, cathepsin S/, and Ii/ mice were stained with TCR- and NK1.1
antibodies and analyzed by FACS. There are decreased NK1.1 T cells in both thymocyte and splenocyte cell preparations from cathepsin
S/ and Ii/ mice, with a more marked decrease in thymocytes.
(B) HSA- and CD8-depleted thymocytes from wild-type, cathepsin S/, and CD1/ mice were stained for the presence of V8 and CD44high
T cells, as a surrogate for NK1.1 T cells. There are decreased numbers of V8/CD44high T cells in the thymus of cathepsin S/ mice, similar
to that seen in the CD1/ thymus.
(C) FACS analysis of splenocytes and thymocytes from wild-type and cathepsin S/ mice following staining with -GalCer-CD1 tetramers to
identify T cells expressing invariant V14J281 TCR. As in (A) and (B) above, cathepsin S/ mice are deficient in this cell population.
(D) Splenocytes, thymocytes, and flt3L-derived DCs from wild-type (continuous line) and cathepsin S/ (stippled line) mice were stained with
anti-CD1 and analyzed by FACS. There is no difference in CD1 expression on these cells. HSA, heat-specific antigen; WT, wild-type.
NK1.1 T cell numbers alone, or is there an additional respectively, as compared with wild-type thymocytes.
Thus, thymic APCs from cathepsin S/ mice displayantigen presentation defect? To investigate this possi-
bility more directly, thymocytes, depleted of TCR- impaired CD1d function. Interestingly, Ii/ thymic APC
display no defect in processing and presentation ofand NK1.1 cells, were utilized as APCs in presentation
of -GalCer and Gal(1→2)-galactosylceramide -GalCer or Gal(1→2)-GalCer, indicating that the de-
fect in NK1.1 T cell selection seen in these animals(Gal(1→2)-GalCer), a digalactose analog of -GalCer,
to the CD1-restricted T cell hybridoma 3C3 (Figure 2C). potentially occurs via a different mechanism (data not
shown).Gal(1→2)-GalCer was used along with the monosac-
charide -GalCer because it has a stringent requirement In an independent set of experiments, thymic DCs (I-Ab/
CD8) and NK1.1 cells were purified by sorting fromfor endosomal trafficking and processing (Prigozy et al.,
2001). Depleted thymocytes from cathepsin S/ mice wild-type and cathepsin S/ thymi, and CD1-depen-
dent antigen presentation assays performed in the pres-are deficient in their ability to present either -GalCer
or Gal(1→2)-GalCer to 3C3 cells, as compared with ence of -GalCer (Figure 2D). These experiments were
conducted to pinpoint and certify CD1d dysfunction inwild-type thymocytes. 3C3 cells alone (without APCs)
are capable of low-level autostimulation with both anti- cathepsin S/ thymic DCs, and to look at whether ca-
thepsin S/ NK1.1 T cells are able to recognize andgens (closed triangles), as they express low levels of
CD1. When taking this autostimulation into account, IL2 respond to CD1d antigens. Cathepsin S/ DCs (open
circles), as compared with wild-type (open squares),generation using cathepsin S/ APC is decreased by
75% and80% for -GalCer and Gal(1→2)-GalCer, generate a markedly reduced IFN- response from wild-
Immunity
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Figure 2. Defective CD1-Dependent Function of Cathepsin S/ APCs and NK1.1 T Cells
(A) Thy1.2-depleted splenocytes derived from wild-type (closed circles) and cathepsin S/ (open circles) animals were incubated with CD1-
restricted T cell hybridomas for 24 hr. IL2 levels in the supernatants were measured by ELISA.
(B) Thymocytes (106 /well) from wild-type and cathepsin S/ mice were incubated with vehicle and 100 ng/ml of -GalCer for 48 hr. The
differences in cytokine generation between vehicle- and -GalCer-treated cells were measured by ELISA. Cathepsin S/ thymocytes show
a markedly attenuated cytokine response, IFN- more affected than IL4, as compared with wild-type. Thymocytes depleted of class II cells
fail to elicit normal IFN- and IL4 responses. Data (mean  SEM of triplicates) represent the change in cytokine generation between controls
(without -GalCer) and experimentals. In the absence of -GalCer control wells generated 0.7 ng/ml IFN- and undetectable levels of IL4.
(C) Thymocytes (500 k/well), depleted of TCR- and NK1.1 cells, were incubated with 3C3 cells (100 k/well) for 24 hr in the presence of
-GalCer or Gal(1→2)-GalCer. Cathepsin S/ thymic APCs (open circles) are defective in their ability to present these CD1-restricted
antigens to T cells, as compared with wild-type (closed circles). 3C3 cells alone generate a small amount of IL2 when incubated with maximal
concentrations of -GalCer and Gal(1→2)-GalCer (closed triangles). Each data point represents the mean  SEM of three wells. APCs with
antigens alone (no 3C3 cells) failed to generate measurable IL2.
(D) Thymic DCs (class II/CD8) and NK1.1 T cells from wild-type and cathepsin S/ mice were isolated by FACS sorting and incubated
together in the presence of 100 ng/ml -GalCer for 48 hr. Cathepsin S/ DCs (open circles) exhibit a striking defect in stimulating wild-type
NK1.1 T cells (30 k/well) to generate IFN-, but not IL4, as compared with wild-type DCs (open squares). Cathepsin S/ NK1.1 T cells (30
k/well) are unable to generate either cytokine when stimulated with wild-type DCs (closed triangles). Each data point represents the mean 
SEM from triplicate wells. Control wells (no -GalCer) failed to generate any measureable IFN- or IL4.
type NK1.1T cells. Interestingly, the ability of cathepsin dependent antigen presentation. One potential mecha-
nism for these data, i.e., aberrant intracellular traffickingS/ DCs to generate an IL4 response from wild-type
NK T cells is not affected. Furthermore, the NK1.1 T cells of CD1 caused by accumulation of Ii fragments and
class II-Ii complexes, is investigated in the remainder offrom cathepsin S/ mice are markedly defective in their
response to-GalCer presented by wild-type DC (closed this manuscript.
triangles). They fail to generate either IFN- or IL4, sug-
gesting that a maturational defect in NK1.1 T cell devel- Aberrant CD1 Intracellular Trafficking
in Cathepsin S/ APCsopment secondary to defective CD1 functioning on thy-
mic DCs may be a contributing factor. Regardless, the The processing of Ii and its fragments by cathepsin S
regulates the intracellular trafficking of MHC class IIabnormal thymic selection and function of NK1.1 T cells
seen in cathepsin S/ mice is linked to defective CD1- molecules in B cells and DCs (Brachet et al., 1997;
Cathepsin S Regulates NK1.1 T Cell Selection
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Driessen et al., 1999; Pierre and Mellman, 1998). This did not. This finding can be explained by differences in
affinity of the class II molecules for the Ii fragmentsdefect is especially pronounced in APCs from I-Ab, ca-
thepsin S/ animals. Mouse CD1d, like class II, requires (Sette et al., 1995). The lower affinity of the I-Ak class II
molecules for Ii fragments, compared with I-Ab class II,endosomal trafficking for acquisition and subsequent
display of some CD1d-restricted antigens (Chiu et al., permits dissociation of class II-lip10 Ii complexes in the
absence of complete Ii degradation. One may exploit1999). To determine if the intracellular trafficking path-
way for mouse CD1d is likewise disrupted in APCs from these haplotypic variations to examine whether the ef-
fects of cathepsin S deficiency result directly from losscathepsin S/ mice, confocal colocalization studies
were conducted in cathepsin S/ flt3L-derived DCs of enzyme activity or are secondary to incomplete Ii
degradation and disrupted class II trafficking within the(Figure 3). There is an impressive accumulation of endo-
somal CD1d molecules in cathepsin S/ DCs, with in- endosomes of APCs. If the latter explanation is correct,
one would expect a far milder phenotype in I-Ak mice.creased colocalization of CD1d with class II, Ii, and ca-
thepsin D molecules. In fact, quantitative analysis of Homozygous I-Ak cathepsin S/mice were generated
from C3H parents. To show that indeed APCs from thesethese images reveal an almost 100% colocalization of
CD1d and the N terminus of the Ii in cathepsin S/ cathepsin S/ mice do not accumulate as much class
II-lip10 Ii complexes as I-Ab APCs, splenocytes wereDCs. Thus, similar to that observed with MHC class II
complexes, the intracellular trafficking of CD1d is nota- metabolically labeled with 35S-methionine/cysteine,
chased for 4 hr, and class II complexes subsequentlybly disrupted in I-Ab, cathepsin S/ mice. In Ii/ flt3L-
derived DCs, there is no colocalization of CD1d with immunoprecipitated (Figure 5A). The quantity of class
II-lip10 Ii in the I-Ak, cathepsin S/ splenocytes remainsintracellular MHC class II or cathepsin D, again indicat-
ing the molecular and cellular bases for defective NK1.1 at baseline, whereas there is clear class II-lip10 Ii buildup
in the I-Ab, cathepsin S/ cells. To correlate our bio-T cell selection in Ii/ and cathepsin S/ may be dis-
tinct (data not shown). chemical data with the T cell phenotype, thymic cells
were stained with CD1--galactosylceramide tetramers
for detection of T cells expressing the V14J281 TCRCathepsin S and lip10 Ii Are Not Expressed
(Figure 5B). Both splenocytes and thymocytes from I-Ab,in Thymic T Cells
cathepsin S/ animals demonstrate a clear reduction inThe distribution of cathepsin S and Ii in thymic cells is
the number of T cells that express V14J281 TCR,critical for elucidating the cathepsin S/ phenotype. To
whereas cells from I-Ak, cathepsin S/ animals showstudy the distribution of cathepsin S activity in thymic
no significant difference as compared with wild-typecell preparations, thy1.2 thymocytes were sorted by
littermate controls. These findings extend to CD1-stimu-FACS and the activity of cysteine proteases determined
lated cytokine release. In contrast to I-Ab thymic cells,by labeling cell lysates with 125I-JPM-565, followed by
I-Ak, cathepsin S/ thymic cells do not exhibit an attenu-SDS-PAGE and autoradiography (Figure 4A). 125I-JPM-
ated IFN- or IL4 response to -GalCer (Figure 5C).565 irreversibly binds to cysteine proteases in propor-
Taken together, our data strongly implicate disruptedtion to their activity (Bogyo et al., 2000; Meara and Rich,
intracellular trafficking, caused by MHC class II-lip10 Ii1996). Cathepsin S activity is discernable only in the
accumulation, in defective CD1d function and selectionunsorted, and not thy1.2, thymocytes, consistent with
of NK1.1 T cell in cathepsin S/ mice.its expression in APCs and not T cells. By immunoblot
analysis, expression of Ii and lip10 Ii follows a very similar
pattern of distribution, occurring almost exclusively in Discussion
unsorted thymic cells (Figure 4B). Similar to splenocytes
and flt3L-derived DCs, unsorted thymic cells exhibit The critical involvement of cathepsin S in Ii degradation
marked accumulation of class II-lip10 Ii complexes in and class II trafficking in peripheral APCs is well estab-
cathepsin S/ mice. Low-level Ii expression is seen in lished. Cathepsin L may play an analogous role in corti-
CD4/CD8 T cells (Figure 4C). However, these CD4/ cal thymic epithelial cells and is required for normal
CD8 cells from cathepsin S/ mice fail to accumulate selection of CD4 T cells. These findings have prompted
lip10 Ii, consistent with the observation that cathepsin immunologists to advance the paradigm that differential
S is not expressed in T cells, and therefore is not involved expression of cysteine proteases, cathepsin S peripher-
in degradation of full-length Ii in these cells. Thus, the ally versus cathepsin L centrally, allows complementary
fact that cathepsin S and lip10 Ii are expressed exclu- regulation of thymic T cell selection and peripheral T cell
sively in thymic APCs, and not T cells, implies that the stimulation/activation (Cresswell, 1998). The results re-
NK1.1 T cell dysfunction observed is mediated through ported here necessitate a shifting of this theme, that
these class II thymic APCs. both cathepsins S and L are required for normal T cell
selection, but that each may be required for a different
thymic T cell population. Thus, the complementary char-Abnormal NK1.1 T Cell Selection
Is Haplotype Dependent acter of cathepsins S and L in development of immunity
may not in fact be central versus peripheral, but con-The effects of cathepsin S deficiency on accumulation
of class II-lip10 Ii complexes, and by implication, its tained within the thymus itself. Both cathepsins S and
L appear to exert their central effects through theireffects on class II trafficking, is strongly haplotype de-
pendent. Villadangos et al. (1997) demonstrated that involvement in Ii degradation, although each may act in
different thymic APC populations.APCs from mice expressing I-Ab or I-Ad class II molecules
exhibited build-up of class II-lip10 Ii complexes upon What are the cells that mediate selection and matura-
tion of thymic NK1.1 T cells? Previous studies usingcathepsin S inhibition, whereas APCs from I-Ak mice
Immunity
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Figure 3. Aberrant CD1d Intracellular Traf-
ficking in Cathepsin S/ DCs
Flt3L-derived DCs were isolated from wild-
type (left panels) and cathepsin S/ (right
panels) spleens and analyzed by confocal mi-
croscopy to look for colocalization of CD1d
with class II (upper panels), N terminus Ii (sec-
ond set of panels from top), C terminus Ii
(third set of panels from top), and cathepsin D
(bottom panels). In cathepsin S/ DCs, CD1d
accumulates within endosomes and colocal-
izes with class II, Ii, and cathepsin D. The
merged image from the green and red fluores-
cence of one representative cell is displayed
(left cell of each panel). A colocalization anal-
ysis was performed for the same cell (right
cell of each panel), showing the content of all
intracellular compartments that display CD1d
molecules.
SCID chimeric mice have firmly established CD4CD8 state being unable to express large amounts of IL4 and
IFN- upon stimulation. Thus, these cells are phenotypi-T cells as critical in selection and maturation of NK1.1
T cells (Bendelac, 1995b; Bendelac et al., 1994). Our cally distinct from NK1.1 T cells derived from wild-type
animals. DCs appear to augment selection of NK1.1data point to thymic DCs as an additional cell type that
plays an important role. First, T cells do not express T cells within the thymus as well as mediate cytokine
activation within these cells to complete the differentia-cathepsin S and therefore a deficiency of this enzyme
is unlikely to directly alter T cell function. Second, Ii tion. The signaling mechanism for this step in NK1.1 T
cell maturation is regulated by class II and Ii within thy-expression is found only on CD4CD8, and not on
CD4CD8, or other T cells. Third, I-Ab, cathepsin S/ mic DCs. Thus, use of the cathepsin S/ animals has
revealed a previously unknown interaction among thy-mice have normal numbers of thymic CD4CD8 T cells
and express a normal level of cell surface CD1d by FACS mic DCs, CD4CD8, and NK1.1 T cells, and exempli-
fies the importance of the integrative thymic environ-analysis. Finally, there is a clear abnormality in NK1.1
T cells derived from cathepsin S/ animals in their abil- ment in maturation and development of NK1.1 T cells.
The attenuation in presentation of the CD1d-restrictedity to generate IL4 and IFN- when stimulated through
their TCR. epitope Gal(1→2)-GalCer as well as the colocalization
of intracellular CD1d with MHC class II, Ii, and cathepsinBased on these data, we propose a model in which
both thymic DCs and CD4CD8 T cells play a role in D strongly argue for a CD1d trafficking defect in cathep-
sin S/ APCs. Gal(1→2)-GalCer is a derivative ofselection and maturation of NK1.1 T cells. CD4CD8
T cells are necessary, but not sufficient, for normal selec- -GalCer and requires endosomal processing by
-galactosidase A prior to recognition by V14J281tion and maturation/differentiation of the full repertoire
of NK1.1 T cells. In this model, CD4CD8 T cells within TCR (Prigozy et al., 2001). The data on whether endoso-
mal trafficking of -GalCer is required for presentationthe thymus are able to mediate differentiation of NK T cells
to express CD44 and CD69. Some, but not all, of these is somewhat equivocal. Presentation of -GalCer by
splenic DCs is completely abrogated by administrationCD1d-dependent T cells are also able to express TCR
and the NK1.1 antigen, but remain in a less activated of chloroquine or concanamycin A, indicating a require-
Cathepsin S Regulates NK1.1 T Cell Selection
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Figure 4. Cathepsin S and lip10 Ii Distributes with Class II, and Not thy1.2, Thymic Cells
(A) Thymocytes from wild-type and cathepsin S/ mice were sorted for thy1.2high surface expression, lysed, and labeled with 125I-JPM-565
(6 million cells/lane). Unsorted thymocytes were run as controls. Cathepsin S is expressed only in the wild-type, unsorted thymocytes.
(B) Thymocytes from wild-type and cathepsin S/ mice were sorted for thy1.2high surface expression followed by immunoblot analysis for Ii
and Ii fragments (In-1 antibody, 5 million cells/lane). Ii has a similar distribution in the thymus as cathepsin S. Cathepsin S/ thymocytes
accumulate lip10 Ii, similar to that seen with peripheral APCs.
(C) Thymocytes were sorted for class II, CD4, and CD8 surface expression, followed by immunoblotting for Ii. Ii and Ii fragments are primarily
distributed with class II cells, although a small amount of full-length Ii is found in CD4CD8 thymocytes.
ment for endosomal function (Kawano et al., 1997). In and maturation might be highly dependent upon endo-
somal trafficking. This hypothesis is supported by thecontrast, CD1-transfected thymocytes are able to effec-
tively present -GalCer following fixation or treatment observation that the reduction in NK1.1 T cells within
the spleen of -galactosidase A/ animals is similarwith concanamycin A, suggesting that endosomal traf-
ficking is not a requirement for CD1-mediated presenta- in magnitude to the reduction seen in cathepsin S/
animals (Prigozy et al., 2001).tion of -GalCer in these cells (Burdin and Kronenberg,
1999). Our data that presentation of -GalCer is blocked Although the requirement for endosomal trafficking in
presentation of all CD1-restricted antigens is not abso-to a similar extent as Gal(1→2)-GalCer in thymic DCs
suggests that endosomal trafficking is required for pre- lute, disruption of this pathway may have profound effects
on CD1d function within the cathepsin S/ DCs. Experi-sentation of this epitope in these cells. Regardless of
the case for -GalCer, CD1-mediated presentation of ments utilizing CD1d mutants, which lack the targeting
motif in the cytoplasmic tail and hence do not undergoexogenous ligand(s) required for NK1.1 T cell selection
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Figure 5. Abnormal NK1.1 T Cell Selection and CD1 Function Is Haplotype Dependent
(A) Splenocytes from I-Ab and I-Ak, wild-type and cathepsin S/ mice were pulsed with 35S-methionine, cysteine and chased for 4 hr, followed
by immunoprecipitation of class II complexes and SDS-PAGE analysis. Samples were run under both nonboiled (nb) and boiled (b) conditions
to delineate the SDS-stable but heat labile class II-peptide (/peptide) complexes.
(B) Splenocytes and thymocytes from I-Ab and I-Ak, wild-type and cathepsin S/ mice were stained with -GalCer-CD1 tetramers and analyzed
by FACS. There is no significant NK1.1 T cell selection defect in I-Ak spleen or thymus.
(C) Thymocytes from I-Ab and I-Ak, wild-type and cathepsin S/ mice were isolated and incubated with 100 ng/ml -GalCer for 48 hr. Cytokine
generation was determined by ELISA. Data represent mean  SEM difference in IFN- and IL4 generation between control wells (no -GalCer)
and experimentals, each run in triplicate.
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intracellular trafficking, demonstrate a defect in their ability sin S/ mouse? Cathepsin S/ mice exhibit an attenu-
to generate an autologous CD1d-bound ligand that stimu- ated Th1 type immune response, e.g., decreased IgG2a
lates V14NK1.1 but not V14-NK1.1 CD1-restricted and IgG3 production following immunization with
T cell hybridomas (Chiu et al., 1999). Given these find- Freund’s adjuvant, while maintaining normal Th2 type
ings, one could hypothesize that cathepsin S/ APC immunity, as exemplified by normal IgE levels in a murine
would behave similarly to the CD1d mutants in their ability model of pulmonary hypersensitivity (Shi et al., 1999,
to stimulate V14 but not V14 CD1-restricted T cells. 2000). One possible link between CD1 function and the
However, this is not the case. The ability of cathepsin S/ Th2 bias seen in cathepsin S/ mice is our finding that
splenocytes to activate the CD1-restricted T cell hybrido- the decrease in -GalCer-stimulated IFN- production
mas is dependent on the specific hybridoma and not by cathepsin S/ thymic DCs is more pronounced than
on the TCR  chain expression (Figure 2A). This makes the decrease in IL4 generation. This could potentially
a certain amount of sense in light of the confocal data influence the adaptive immune response at an early
showing that CD1d is taken up very well in cathepsin stage. The alterations in CD1 function observed for the
S/ DCs, thus displaying a distinct trafficking pattern cathepsin S/ animals, as well as abnormalities in the
from the CD1d tail mutants that do not sample the intra- MHC class II biosynthetic pathway, may play an impor-
cellular environment at all. It is likely that CD1d mole- tant role in modulating the integrative immune response.
cules trafficking to different intracellular compartments In summary, in mice expressing class II molecules with
are affected/altered to varying degrees dependent on high affinity for Ii and Ii fragments, inhibition of cathepsin
the quantity of colocalizing class II-Ii complexes in each S activity leads to abnormal selection and maturation/
specific endosome. The alterations in trafficking and differentiation of the CD1-restricted NK1.1 T cells. This
CD1d endosomal sampling found in cathepsin S/ APC phenotype correlates well with abnormal intracellular
are potentially very complex. CD1d trafficking and defective CD1-restricted antigen
These findings also underscore the fine interplay be- presentation, suggesting a causal relationship. Further-
tween molecules clearly involved in the MHC class II more, the finding that I-Ak do not exhibit this NK1.1
(Ii and cathepsin S) and the CD1 antigen presentation T selection defect implies that these alterations are me-
pathways within APCs. Proper processing of the class II- diated through intracellular accumulation of Ii fragments,
associated Ii appears to be required not only for normal perhaps as a consequence of a dominant-negative traf-
class II trafficking but also for intracellular routing and ficking defect. These findings illustrate the intricate inter-
function of CD1d. However, the structural interactions play between the innate and adaptive immune responses,
between CD1d and Ii are clearly not as direct as between and highlight the importance of these interactions in the
CD1 and 2-microglobulin, or as between Ii and class development of immunity.
II. We were unable to demonstrate direct Ii-CD1 associa-
tion by in vitro translation of their respective mRNAs
Experimental Proceduresunder conditions where assembly of classical class I
products readily occurs (H.P., unpublished data). In-
Mice
stead, the failure to destroy Ii likely produces a “domi- Cathepsin S/ mice were backcrossed to C57Bl/6 mice for at least
nant-negative” effect on intracellular trafficking caused ten generations. Wild-type C57Bl/6 mice were used as controls
by the accumulation of Ii fragments. Ii contains a leucine- (Jackson Laboratories). All animals were maintained under pathogen
free conditions at the animal facilities of Harvard Medical Schoolbased targeting motif in its N terminus, whereas CD1d
and the University of California at San Francisco in compliance withcontains a tyrosine-based motif. Both these motifs can
institutional guidelines and used at 6–10 weeks of age. Cathepsincompete for the same intracellular trafficking machinery,
S/mice expressing homozygous I-Ak were also generated by inter-as inferred from delayed uptake of the transferrin recep-
breeding. Littermate I-Ak (C3H), cathepsin S/ animals were used
tor following overexpression of either Ii or CD1 mole- as controls.
cules (Nordeng and Bakke, 1999). Alternatively, inactiva-
tion of cathepsin S within APC may disrupt the normal
Antibodiesproteolytic environment resulting in both abnormal traf-
Antibodies against mouse NK1.1, TCR-, V8, CD44, HSA, CD8,ficking of CD1d and processing of CD1d-restricted anti-
MHC class II, thy1.2, CD4, Ii (In1), CD1, and CD3, as well as isotypegens. For example, a recent study has identified increased
controls for the FACS analysis, were all purchased from PharMingen.
levels of mature -interferon-inducible lysosomal thiol re- JV2 (MHC class II  chain), JV5 (N terminus Ii), and JV11 (C terminus
ductase and cathepsin L in cathepsin S/ splenocytes Ii) were generated as previously described (Driessen et al., 1999).
(Honey et al., 2001). Also, flt3L-derived DCs from cathep- Cathepsin D antibody was from Santa Cruz.
sin S/ mice exhibit enlarged endocytic compartments
(Driessen et al., 1999). However, the distribution of trans-
Cell Preparation
ferrin receptor and the B cell receptor appear unaffected Whole thymocyte suspensions were enriched for NK1.1 T cells
in I-Ab, cathepsin S/APC, and argues against a general by complement lysis of HSA- and CD8-positive cells. In brief, cell
defect in endocytosis and intracellular trafficking in ca- suspensions were incubated with anti-HSA and anti-CD8 antibodies
thepsin S/ cells that also express Ii (Driessen et al., at 4	C for 30 min. After removal of unbound antibody by washing,
rabbit complement (Accurate) was used to lyse HSA and CD81999) (H.A.C., unpublished data). These data, when
cells (37	C, 45 min). This resulted in a 95% reduction in total celltaken together, suggest that CD1 “straddles” both the
number and virtually complete elimination of HSA or CD8 cells.class I and class II antigen presentation pathways by sam-
The resulting NK1.1 T cell-enriched thymocyte-populations (thy-
pling both class I and class II environments and coopting mocytes [HSA, CD8] were routinely characterized by FACS (CD4, CD8,
required associated molecules for proper functioning. TCR-) and were consistent within each experiment as well as between
Can the abnormalities in NK1.1 T cell selection and individual experiments. Similar methodology was used to generate
class II-deficient thymocytes and thy1.2-depleted splenocytes.CD1 function help explain the phenotype of the cathep-
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FACS Analysis and CD1--galactosylceramide in RPMI medium containing 10% goat serum (GIBCO-BRL) and
0.05% saponin for 15 min. The primary and secondary antibodyTetramer Staining
For FACS analysis, single-cell suspensions were incubated for 30 solutions were prepared in the same medium. Cells were incubated
with the antibodies for 30 min, washed 3, mounted in Aquapoly/min at 4	C either with the appropriate conjugated antibodies or a
nonconjugated primary antibody, washed, and then at least 20,000 Mount solution (Polysciences), and analyzed in a Bio-Rad MRC 1024
confocal laser scanning microscope. The merged images were ana-cells for each panel analyzed on a FACScan (Becton Dickinson)
using Cell Quest software. Isotype controls were included in all lyzed for the presence of CD1 in class II, Ii, and cathepsin D positive
structures using the colocalization program from Bio-Rad.experiments.
Soluble murine CD1d molecules were generated, loaded with
-GalCer or a vehicle control, and coupled to fluorescent neutravi- Active Site Labeling, Immunoblotting, and Immunoprecipitation
din-PE as described (Matsuda et al., 2000). Cell suspensions were The cysteine protease active site inhibitor JPM-565 (Meara and Rich,
stained at 2 108 /ml for 45 min with predetermined optimal concen- 1996) was iodinated via an iodogen-catalyzed reaction. Thymocytes
trations of CD1d tetramers and cooled on ice before addition of were stained with anti-thy1.2 antibody, washed, and positively
antibodies and staining for an additional 45 min: -NK1.1-FITC, stained cells sorted using a MoFlo flow cytometer with CyClone
-CD8-TriColor (CalTag), -CD45R/B220-TriColor (CalTag), and hardware (Cytomation). Sorted and unsorted thymocytes (6 million/
-CD3-APC. Following washing, cells were resuspended at a final sample) were incubated with 125I-JPM-565 and analyzed by SDS-
concentration of 2 107 /ml and analyzed on a dual laser FACSCali- PAGE as described (Shi et al., 2000). To analyze the distribution of Ii,
bur flow cytometer (Becton Dickinson). Acquired data were analyzed lysates of thymocyte subpopulations were analyzed by SDS-PAGE,
using FlowJo software (Treestar, Inc). transferred to nitrocellulose and immunoblotted with anti-Ii. MHC
class II processing was analyzed by pulse-chase analysis of meta-
bolically labeled cells as previously described (Riese et al., 1996).Antigen Presentation Assays
Thymocytes and splenocytes from wild-type and cathepsin S/
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